1020495

StemImmune, Inc — FEI 3013559264

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 4, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
San Diego, CA (United States)